KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 134 filers reported holding KARUNA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 2.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $26,693,224 | +7.3% | 157,864 | +15.2% | 0.01% | 0.0% |
Q2 2023 | $24,880,685 | 0.0% | 136,978 | 0.0% | 0.01% | 0.0% |
Q1 2023 | $24,880,685 | +16.4% | 136,978 | +25.9% | 0.01% | +9.1% |
Q4 2022 | $21,381,560 | -99.9% | 108,812 | +3.1% | 0.01% | -15.4% |
Q3 2022 | $23,742,035,000 | +13.9% | 105,553 | -35.9% | 0.01% | +18.2% |
Q2 2022 | $20,837,336,000 | -32.4% | 164,709 | -32.3% | 0.01% | -15.4% |
Q1 2022 | $30,838,626,000 | -2.1% | 243,226 | +1.2% | 0.01% | +8.3% |
Q4 2021 | $31,498,033,000 | +18.9% | 240,443 | +11.0% | 0.01% | +9.1% |
Q3 2021 | $26,492,153,000 | +1.1% | 216,563 | -5.8% | 0.01% | 0.0% |
Q2 2021 | $26,203,679,000 | -5.4% | 229,877 | -0.2% | 0.01% | -8.3% |
Q1 2021 | $27,702,796,000 | +9.8% | 230,415 | -7.2% | 0.01% | 0.0% |
Q4 2020 | $25,237,496,000 | +45.2% | 248,425 | +10.5% | 0.01% | +33.3% |
Q3 2020 | $17,378,984,000 | -30.7% | 224,767 | -0.1% | 0.01% | -40.0% |
Q2 2020 | $25,078,612,000 | +118.5% | 225,001 | +41.1% | 0.02% | +87.5% |
Q1 2020 | $11,478,456,000 | – | 159,423 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 908,708 | $109,254,000 | 35.05% |
Sofinnova Investments, Inc. | 1,952,441 | $234,742,000 | 14.11% |
Logos Global Management LP | 200,000 | $24,046,000 | 2.35% |
First Light Asset Management, LLC | 258,500 | $31,079,000 | 2.06% |
Eventide Asset Management | 971,077 | $116,753,000 | 1.73% |
DAFNA Capital Management LLC | 48,000 | $5,771,000 | 1.37% |
CATALYST PRIVATE WEALTH, LLC | 13,006 | $1,564,000 | 1.10% |
Rock Springs Capital Management LP | 368,764 | $44,336,000 | 0.97% |
Pinz Capital Management, LP | 28,805 | $3,463,000 | 0.92% |
MILLER VALUE PARTNERS, LLC | 291,239 | $35,016,000 | 0.91% |